91 related articles for article (PubMed ID: 20922561)
21. The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease.
Spirig R; Tsui J; Shaw S
Cardiol Res Pract; 2012; 2012():181394. PubMed ID: 22577589
[TBL] [Abstract][Full Text] [Related]
22. The future of autoimmunity.
Shoenfeld Y
Clin Rev Allergy Immunol; 2012 Apr; 42(2):113-20. PubMed ID: 22203433
[TBL] [Abstract][Full Text] [Related]
23. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
Front Immunol; 2019; 10():179. PubMed ID: 30800129
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus.
Martínez T; Garcia-Robledo JE; Plata I; Urbano MA; Posso-Osorio I; Rios-Serna LJ; Barrera MC; Tobón GJ
Autoimmun Rev; 2019 Mar; 18(3):279-286. PubMed ID: 30639648
[TBL] [Abstract][Full Text] [Related]
25. IVIg attenuates TLR-9 activation in B cells from SLE patients.
Kessel A; Peri R; Haj T; Snir A; Slobodin G; Sabo E; Rosner I; Shoenfeld Y; Toubi E
J Clin Immunol; 2011 Feb; 31(1):30-8. PubMed ID: 20922561
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
27. B cell-activating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells.
Yehudai D; Snir A; Peri R; Halasz K; Haj T; Odeh M; Kessel A
Scand J Immunol; 2012 Oct; 76(4):371-7. PubMed ID: 22725135
[TBL] [Abstract][Full Text] [Related]
28. Response to ODN-CpG by B Cells from patients with systemic lupus erythematosus correlates with disease activity.
Zorro S; Arias M; Riaño F; Paris S; Ramírez LA; Uribe O; García LF; Vásquez G
Lupus; 2009 Jul; 18(8):718-26. PubMed ID: 19502268
[TBL] [Abstract][Full Text] [Related]
29. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
30. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
Wagner M; Poeck H; Jahrsdoerfer B; Rothenfusser S; Prell D; Bohle B; Tuma E; Giese T; Ellwart JW; Endres S; Hartmann G
J Immunol; 2004 Jan; 172(2):954-63. PubMed ID: 14707068
[TBL] [Abstract][Full Text] [Related]
31. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.
Guiducci C; Gong M; Xu Z; Gill M; Chaussabel D; Meeker T; Chan JH; Wright T; Punaro M; Bolland S; Soumelis V; Banchereau J; Coffman RL; Pascual V; Barrat FJ
Nature; 2010 Jun; 465(7300):937-41. PubMed ID: 20559388
[TBL] [Abstract][Full Text] [Related]
32. IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes.
Séïté JF; Cornec D; Renaudineau Y; Youinou P; Mageed RA; Hillion S
Blood; 2010 Sep; 116(10):1698-704. PubMed ID: 20516366
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg).
Paquin Proulx D; Aubin E; Lemieux R; Bazin R
Clin Immunol; 2010 Jun; 135(3):422-9. PubMed ID: 20138586
[TBL] [Abstract][Full Text] [Related]
34. Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.
Illei GG; Shirota Y; Yarboro CH; Daruwalla J; Tackey E; Takada K; Fleisher T; Balow JE; Lipsky PE
Arthritis Rheum; 2010 Feb; 62(2):542-52. PubMed ID: 20112381
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous internalization of IVIg in activated B cells.
Proulx DP; Aubin E; Lemieux R; Bazin R
Immunol Lett; 2009 May; 124(1):18-26. PubMed ID: 19465239
[TBL] [Abstract][Full Text] [Related]
36. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
